Polyclonality overcomes fitness barriers in Apc-driven tumorigenesis
Nature · 31.10.2024 · 634 (8036) · 1196-1203
DOI: 10.1038/s41586-024-08053-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature, online erschienen am 30.10.2024. Verfasst von Iannish D Sadien und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK. Hauptthemen laut MEDLINE: Adenomatous Polyposis Coli Protein, Cell Lineage, Cell Transformation, Neoplastic, Clone Cells. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Loss-of-function mutations in the tumour suppressor APC are an initial step in intestinal tumorigenesis 1,2 . APC -mutant intestinal stem cells outcompete their wild-type neighbours through the secretion of Wnt antagonists, which accelerates the fixation and subsequent rapid clonal expansion of mutants 3–5 . Reports of polyclonal intestinal tumours in human patients and mouse models appear at odds with this process 6,7 . Here we combine multicolour lineage tracing with chemical mutagenesis in mice to show that a large proportion of intestinal tumours have a multiancestral origin. Polyclonal tumours retain a structure comprising subclones with distinct Apc mutations and transcriptional states, driven predominantly by differences in KRAS and MYC signalling. These pathway-level changes are accompanied by profound differences in cancer stem cell phenotypes. Of note, these findings are confirmed by introducing an oncogenic Kras mutation that results in predominantly monoclonal tumour formation. Further, polyclonal tumours have accelerated growth dynamics, suggesting a link between polyclonality and tumour progression. Together, these findings demonstrate the role of interclonal interactions in promoting tumorigenesis through non-cell autonomous pathways that are dependent on the differential activation of oncogenic pathways between clones.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK.
- Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK.
- Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
- Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK. doug.winton@cruk.cam.ac.uk.
ORCID-Profile: Iannish D Sadien, Shenay Mehmed, Ashley Sawle, Dominique-Laurent Couturier, Matthew Eldridge, David J Adams, Filipe C Lourenço, Douglas J Winton
Zitieren
APA
Sadien, I. D., Adler, S., Mehmed, S., Bailey, S., Sawle, A., Couturier, D. L., Eldridge, M., Adams, D. J., Kemp, R., Lourenço, F. C., & Winton, D. J. (2024). Polyclonality overcomes fitness barriers in Apc-driven tumorigenesis. Nature, 634(8036), 1196-1203. https://doi.org/10.1038/s41586-024-08053-0
Vancouver
Sadien ID, Adler S, Mehmed S, Bailey S, Sawle A, Couturier DL, et al. Polyclonality overcomes fitness barriers in Apc-driven tumorigenesis. Nature. 2024;634(8036):1196-1203. doi:10.1038/s41586-024-08053-0
BibTeX
@article{Sadien2024,
author = {Sadien, Iannish D and Adler, Sam and Mehmed, Shenay and Bailey, Sasha and Sawle, Ashley and Couturier, Dominique-Laurent and Eldridge, Matthew and Adams, David J and Kemp, Richard and Lourenço, Filipe C and Winton, Douglas J},
title = {Polyclonality overcomes fitness barriers in Apc-driven tumorigenesis},
journal = {Nature},
year = {2024},
volume = {634},
number = {8036},
pages = {1196--1203},
doi = {10.1038/s41586-024-08053-0}
}
EUVIMED